Risk factors and treatment of refractory anaphylaxis - a review of case reports

References

• Kemp AM, Kemp SF. Pharmacotherapy in refractory anaphylaxis. Curr Opin Allergy Clin Immunol. 2014;14:371–378.
   PubMed Web of Science ®Google Scholar
• Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report – Second National Institute of allergy and infectious disease/food allergy and anaphylaxis network symposium. Ann Emerg Med. 2006;47:373–380.
   PubMed Web of Science ®Google Scholar
• Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis – a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115:341–384.
   PubMed Web of Science ®Google Scholar
• Houser SM, Weng C, Liu Y-C. A patient with an allergy emergency. JAMA Otolaryngol Head Neck Surg. 2015;141:382.
   PubMed Web of Science ®Google Scholar
• Gouel-Chéron A, Harpan A, Mertes P-M, et al. Management of anaphylactic shock in the operating room. La Presse Médicale. 2016;45:774–783.
   PubMed Web of Science ®Google Scholar
• Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy. 2003;33:1033–1040.
   PubMed Web of Science ®Google Scholar
• Jagdis A, Vadas P. Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndrome. Ann Allergy Asthma Immunol. 2014;113:115–116.
   PubMed Web of Science ®Google Scholar
• Koplin JJ, Martin PE, Allen KJ. An update on epidemiology of anaphylaxis in children and adults. Curr Opin Allergy Clin Immunol. 2011;11:492–496.
   PubMed Web of Science ®Google Scholar
• Tejedor Alonso MA, Moro Moro M, Múgica García MV. Epidemiology of anaphylaxis. Clin Exp Allergy. 2015;45:1027–1039.
   PubMed Web of Science ®Google Scholar
• Fineman SM, Bowman SH, Campbell RL, et al. Addressing barriers to emergency anaphylaxis care: from emergency medical services to emergency department to outpatient follow-up. Ann Allergy Asthma Immunol. 2015;115:301–305.
   PubMed Web of Science ®Google Scholar
• Braganza SC, Acworth JP, Mckinnon DRL, et al. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child. 2006;91:159–163.
   PubMed Web of Science ®Google Scholar
• Worm M, Francuzik W, Renaudin J-M, et al. Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from the European anaphylaxis registry. Allergy. 2018 [Epub ahead of print].
   Google Scholar
• Worm M, Babina M, Hompes S. Causes and risk factors for anaphylaxis. JDDG. 2013;11:44–50.
   Google Scholar
• Lazar I, Cavari Y, Levitas A, et al. Gastric drainage in the treatment of near-fatal food-induced anaphylaxis. Pediatr Emerg Care. 2017;00:1.
   Google Scholar
• Kovalchik S. RISmed: download content from NCBI databases. 2017. Available from https://github.com/skoval/RISmed.
   Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2017.
   Google Scholar
• Stewart WJ, McSweeney SM, Kellett MA, et al. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation. 1984;70:788–792.
   PubMed Web of Science ®Google Scholar
• Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105:259–273.e78.
   PubMed Web of Science ®Google Scholar
• Nag DS, Samaddar DP, Kant S, et al. Perianesthetic refractory anaphylactic shock with cefuroxime in a patient with history of penicillin allergy on multiple antihypertensive medications. Braz J Anesthesiol (English Edition). 2017;67:217–220.
   Google Scholar
• Baumann A, Studnicska D, Audibert G, et al. Refractory anaphylactic cardiac arrest after succinylcholine administration. Anesth Analg. 2009;109:137–140.
   PubMed Web of Science ®Google Scholar
• Simons KJ, Simons FER. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010;10:354–361.
   PubMed Web of Science ®Google Scholar
• Simons FER, Ardusso LRF, Bilò MB, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4:13–36.
   PubMed Web of Science ®Google Scholar
• Tsai C, Slampak-Cindric A. Use of methylene blue in chemotherapy-induced refractory anaphylactic shock. Crit Care Med. 2016;44:543.
   Web of Science ®Google Scholar
• Del Duca D, Sheth SS, Clarke AE, et al. Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin. Ann Thorac Surg. 2009;87:640–642.
   PubMed Web of Science ®Google Scholar
• Rodrigues JM, Pazin Filho A, Rodrigues AJ, et al. Methylene blue for clinical anaphylaxis treatment: a case report. Sao Paulo Med J. 2007;125:60–62.
   PubMed Web of Science ®Google Scholar
• Zweizig S, Roman LD, Muderspach LI. Death from anaphylaxis to cisplatin: a case report. Gynecol Oncol. 1994;53:121–122.
   PubMed Web of Science ®Google Scholar
• Stocche RM, Garcia LV, Reis MPD, et al. Uso do azul de metileno no tratamento de choque anafilático durante anestesia: relato de caso. Rev Bras Anestesiol. 2004;54:809–814.
   PubMedGoogle Scholar
• Liu PY, Lee CH, Lin LJ, et al. Refractory anaphylactic shock associated with ketoconazole treatment. Ann Pharmacother. 2005;39:547–550.
   PubMed Web of Science ®Google Scholar
• Lieberman P, Kemp S, Oppenheimer J, et al. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115:S483–S523.
   PubMed Web of Science ®Google Scholar
• Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69:1026–1045.
   PubMed Web of Science ®Google Scholar
• Enjeti S, Bleecker ER, Smith PL, et al. Hemodynamic mechanisms in anaphylaxis. Circ Shock. 1983;11:297–309.
   PubMedGoogle Scholar
• Lucas KA, Pitari GM, Kazerounian S, et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev. 2000;52:375–414.
   PubMed Web of Science ®Google Scholar
• Omar S, Zedan A, Nugent K. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci. 2015;349:80–88.
   PubMed Web of Science ®Google Scholar
• Schirmer RH, Coulibaly B, Stich A, et al. Methylene blue as an antimalarial agent. Redox Rep. 2003;8:272–275.
   PubMed Web of Science ®Google Scholar
• Buzato MAS, Viaro F, Piccinato CE, et al. The use of methylene blue in the treatment of anaphylactic shock induced by compound 48/80: experimental studies in rabbits. Shock (Augusta, Ga.). 2005;23:582–587.
   PubMed Web of Science ®Google Scholar
• Bauer C, Vadas P, Kelly K. Methylene blue for the treatment of refractory anaphylaxis without hypotension. Am J Emerg Med. 2013;31:753.
   Google Scholar
• Moritoki H, Hisayama T, Takeuchi S, et al. Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta. Br J Pharmacol. 1992;107:196–201.
   PubMed Web of Science ®Google Scholar
• Evora PR, Simon MR. Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue. Ann Allergy Asthma Immunol. 2007;99:306–313.
   PubMed Web of Science ®Google Scholar
• Kessler MR, Eide T, Humayun B, et al. Spurious pulse oximeter desaturation with methylene blue injection. Anesthesiology. 1986;65:435–436.
   PubMed Web of Science ®Google Scholar
• Heytman M, Rainbird A. Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: case studies and review. Anaesthesia. 2004;59:1210–1215.
   PubMed Web of Science ®Google Scholar
• Da Silva PS, Furtado P. Methylene blue to treat refractory latex-induced anaphylactic shock: a case report. AA Case Rep. 2017 Sept 20. doi: 10.1213/XAA.0000000000000630. [Epub ahead of print].
   Google Scholar
• Weiss GM, Fandrick AD, Sidebotham D. Successful rescue of an adult with refractory anaphylactic shock and abdominal compartment syndrome with venoarterial extracorporeal membrane oxygenation and bedside laparotomy. Semin Cardiothorac Vasc Anesth. 2015;19:66–70.
   PubMed Web of Science ®Google Scholar
• Higgins DJ, Gayatri P. Methoxamine in the management of severe anaphylaxis. Anaesthesia. 1999;54:1126.
   PubMed Web of Science ®Google Scholar
• Oliveira Neto AM, Duarte NM, Vicente WV, et al. Methylene blue: an effective treatment for contrast medium-induced anaphylaxis. Med Sci Monitor. 2003;9:CS102–6.
   PubMedGoogle Scholar
• Javeed N, Javeed H, Javeed S, et al. Refractory anaphylactoid shock potentiated by beta-blockers. Catheter Cardio Diag. 1996;39(4):383–384.
   Google Scholar
• Gibbs MW, Kuczkowski KM, Benumof JL. Complete recovery from prolonged cardio-pulmonary resuscitation following anaphylactic reaction to readministered intravenous cefazolin. Acta Anaesthesiologica Scandinavica. 2003;47:230–232.
   PubMed Web of Science ®Google Scholar
• Yee KFH, Wasowicz M. Anaphylaxis and cardiac surgery for hypertrophic obstructive cardiomyopathy: a case report and review of anaesthetic management. Anestezjol Intens Ter. 2016;48:252–256.
   Google Scholar
• Allen SJ, Gallagher A, Paxton LD. Anaphylaxis to rocuronium. Anaesthesia. 2000;55:1223–1224.
   PubMed Web of Science ®Google Scholar
• Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg. 2008;107:620–624.
   PubMed Web of Science ®Google Scholar
• Schummer W, Schummer C, Wippermann J, et al. Anaphylactic shock: is vasopressin the drug of choice? Anesthesiology. 2004;101:1025–1027.
   PubMed Web of Science ®Google Scholar
• Alicia Weissgerber LJ. Methylene blue for refractory hypotension: a case report. AANA J. 2007 Aug;76:271–274.
   Google Scholar
• Hussain AM, Yousuf B, Khan MA, et al. Vasopressin for the management of catecholamine-resistant anaphylactic shock. Singapore Med J. 2008;49:225–228.
   PubMed Web of Science ®Google Scholar
• Lango R, Kowalik MM, Klajbor K, et al. High-volume hemofiltration as rescue therapy for refractory shock after inadvertent rapid aprotinin administration. J Cardiothorac Vasc Anesth. 2009;23:526–528.
   PubMed Web of Science ®Google Scholar
• Bickell WH, Dice WH. Military antishock trousers in a patient with adrenergic-resistant anaphylaxis. Ann Emerg Med. 1984;13:189–190.
   PubMed Web of Science ®Google Scholar
• Avni T, Lador A, Lev S, et al. Vasopressors for the treatment of septic shock: systematic review and meta-analysis. PloS One. 2015;10:e0129305.
   PubMedGoogle Scholar
• Di Chiara L, Stazi GV, Ricci Z, et al. Role of vasopressin in the treatment of anaphylactic shock in a child undergoing surgery for congenital heart disease: a case report. J Med Case Rep. 2008;2:36.
   PubMedGoogle Scholar
• Seedat RY, van der Westhuizen J. Ornipressin for the treatment of adrenaline-resistant anaphylaxis. Curr Allergy Immunol. 2014;27:130–133.
   Google Scholar
• Zaloga GP, Delacey W, Holmboe E, et al. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med. 1986;105:65–66.
   PubMed Web of Science ®Google Scholar
• Laxenaire MC, Torrens J, Moneret-Vautrin DA. [Fatal anaphylactic shock in a patient treated with beta-blockers]. Annales francaises d’anesthesie et de reanimation. 1984;3:453–455.
   PubMedGoogle Scholar
• Raft J, Leclercq M, Longrois D, et al. Récupération hémodynamique et ventilatoire rapide après injection de sugammadex lors d’un choc anaphylactique au rocuronium, réfractaire au traitement conventionnel. Annales Françaises d’Anesthésie et de Réanimation. 2012;31:158–161.
   PubMedGoogle Scholar
• Wang ML, Chang CT, Huang HH, et al. Chlorhexidine-related refractory anaphylactic shock: a case successfully resuscitated with extracorporeal membrane oxygenation. J Clin Anesth. 2016;34:654–657.
   PubMed Web of Science ®Google Scholar
• Gouel-Chéron A, de Chaisemartin L, Jönsson F, et al. Low end-tidal CO2 as a real-time severity marker of intra-anaesthetic acute hypersensitivity reactions. Br J Anaesth. 2017;119:908–917.
   PubMed Web of Science ®Google Scholar
• Sidebotham D, McGeorge A, McGuinness S, et al. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2 – technical considerations. J Cardiothorac Vasc Anesth. 2010;24:164–172.
   PubMed Web of Science ®Google Scholar
• Imamura T, Dubin A, Moore W, et al. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest. 1996;74:861–870.
   PubMed Web of Science ®Google Scholar
• Brown SG, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis? Emergency Med Australas. 2004;16:120–124.
   PubMedGoogle Scholar
• Wittenberg M, Nassiri M, Francuzik W, et al. Serum levels of 9α,11β-PGF 2 and apolipoprotein A1 achieve high predictive power as biomarkers of anaphylaxis. Allergy. 2017;72:1801–1805.
   PubMed Web of Science ®Google Scholar